Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease

NCT02249247 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

577

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Low dose of BIIL 284 BS tablets
DRUG: Medium dose of BIIL 284 BS tablets
DRUG: High dose of BIIL 284 BS tablets
DRUG: Placebo

Sponsor

Boehringer Ingelheim